TriSalus Life Sciences
TLSI
TLSI
49 hedge funds and large institutions have $46.8M invested in TriSalus Life Sciences in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 17 increasing their positions, 2 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
+13
Holders Change %
+36.11%
% of All Funds
0.66%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
21
Increased
17
Reduced
2
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
$10.9M |
| 2 |
AIC
AWM Investment Company
New York
|
$6.81M |
| 3 |
BlackRock
New York
|
$3.39M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
$3.04M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$4.44M |
Top Sellers
| 1 |
Millennium Management
New York
|
$165K |
| 2 |
Citadel Advisors
Miami,
Florida
|
$0 |
| 3 |
Renaissance Technologies
New York
|
$0 |
| 4 |
Goldman Sachs
New York
|
$91.6K |
| 5 |
Lido Advisors
Los Angeles,
California
|
$0 |
